1.Iwasaki, A and Medzihitov, R (2013) Innate response to viral infections. In Knipe, DM and Howley, PM (eds), Fields Virology, 6th Edn. Philadelphia: Wolters Kluwer, pp. 189–253.
2.Graham, BS, Crowe, JE and Ledgerwood, JE (2013) Immunization against viral diseases. In Knipe, DM and Howley, PM (eds), Fields Virology, 6th Edn. Philadelphia: Wolters Kluwer, pp. 374–413.
3.Chang, A and Dutch, RE (2012) Paramyxovirus fusion and entry: multiple paths to a common end. Viruses 4, 613–636.
4.Lamb, RA, Paterson, RG and Jardetzky, TS (2006) Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology 344, 30–37.
5.Bose, S et al. (2013) Mutations in the parainfluenza virus 5 fusion protein reveal domains important for fusion triggering and metastability. Journal of Virology 87, 13520–13531.
6.Almajhdi, FN, Alshaman, MS and Amer, HM (2012) Human parainfluenza virus type 2 hemagglutinin-neuramindase gene: sequence and phylogenetic analysis of the Saudi strain Riyadh 105/2009. Virology Journal 9, 316.
7.Terrier, O et al. (2008) Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants. Journal of Clinical Virology 43, 86–92.
8.Šantak, M et al. (2016) Genetic diversity among human parainfluenza virus type 2 isolated in Croatia between 2011 and 2014. Journal of Medical Virology 88, 1733–1741.
9.Hall, CB (2001) Respiratory syncytial virus and parainfluenza virus. New England Journal of Medicine 344, 1917–1928.
10.Murphy, BR (1988) Current approaches to the development of vaccines effective against parainfluenza viruses. Bulletin of World Health Organization 66, 391–397.
11.Hayden, FG (2006) Respiratory viral threats. Current Opinion in Infectious Diseases 19, 169–178.
12.Weinberg, GA et al. (2009) Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. Journal of Pediatrics 154, 694–699.
13.Rudan, I et al. (2010) Causes of deaths in children younger than 5 years in China in 2008. Lancet 375, 1083–1089.
14.Chanock, RM (1956) Association of a new type of cytopathogenic myxovirus with infantile croup. Journal of Experimental Medicine 104, 555–576.
15.Laurichesse, H et al. (1999) Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975–1997. European Journal of Epidemiology 15, 475–484.
16.Reed, G et al. (1997) Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children 5 years old. Journal of Infectious Diseases 175, 807–813.
17.Yano, T et al. (2014) Epidemiological investigation and seroprevalence of human parainfluenza virus in Mie Prefecture in Japan during 2009–2013. Japanese Journal of Infectious Diseases 67, 506–508.
18.Moisiuk, SE et al. (1998) Outbreak of parainfluenza virus type 3 in an intermediate care neonatal nursery. Pediatric Infectious Diseases Journal 17, 49–53.
19.Cortez, KJ et al. (2001) Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. Journal of Infectious Diseases 184, 1093–1097.
20.Cohen, BJ et al. (2007) Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26, 59–66.
21.Arnold, K et al. (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics (oxford, England) 22, 195–201.
22.Bordoli, L et al. (2009) Protein structure homology modelling using SWISS-MODEL workspace. Nature Protocols 4, 1–13.
23.Biasini, M et al. (2014) SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Research 42, 252–258.
24.Kringelum, JV et al. (2012) Reliable B cell epitope predictions: impacts of method development and improved benchmarking. PLoS Computational Biology 8, e1002829.
25.Ponomarenko, J et al. (2008) Ellipro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 9, 514.
26.Jespersen, MC, et al. (2017) BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Research 45, W24–W29.
27.Hamby, SE and Hirst, JD (2008) Prediction of glycosylation sites using random forests. BMC Bioinformatics 9, 500.
28.Delport, W et al. (2010) Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics (oxford, England) 26, 2455–2457.
29.Numazaki, Y et al. (1968) A variant of parainfluenza type 2 virus. Proceedings of the Society for Experimental Biology and Medicine 127, 992–996.
30.Tsurudome, M et al. (1989) Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies. Virology 171, 38–48.
31.Ray, R, et al. (1992) Distinct hemagglutinin and neuraminidase epitopes involved in antigenic variation of recent human parainfluenza virus type 2 isolates. Virus Research 24, 107–113.
32.Santibanez, S et al. (2002) Rapid replacement of endemic measles virus genotypes. Journal of General Virology 83, 2699–2708.
33.Chen, YY et al. (2011) Japanese encephalitis virus genotype replacement, Taiwan, 2009–2010. Emerging Infectious Diseases 17, 2354–2356.
34.Do, LP, et al. (2015) Molecular epidemiology of Japanese encephalitis in northern Vietnam, 1964–2011: genotype replacement. Virology Journal 12, 51.
35.Spriggs, MK et al. (1987) Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity. Journal of Virology 61, 3416–3423.
36.Örvell, C et al. (1997) Characterization of genotype-specific epitopes of the HN protein of mumps virus. Journal of General Virology 78, 3187–3193.
37.Cusi, MG et al. (2001) Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein. Virus Research 74, 133–137.
38.Bouche, FB, Ertl, OT and Muller, CP (2002) Neutralizing B cell response in measles. Viral Immunology 15, 451–471.
39.Samal, SK (2006) Paramyxoviruses of animals. In Mahy, BWJ and van Regenmortel, MHV (eds), Desk Encyclopedia of Animal and Bacterial Virology. Oxford: Elsevier, pp. 175–182.
40.Šantak, M, Örvell, C and Gulija, TK (2015) Identification of conformational neutralization sites on the fusion protein of mumps virus. Journal of General Virology 96, 982–990.
41.Schmidt, AC et al. (2011) Progress in the development of human parainfluenza virus vaccines. Expert Review in Respiratory Medicine 5, 515–526.